APT Medical Inc. (SHA:688617)

APT Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	993.14	1,081	1,276	250.88	309.66	120.34
Trading Asset Securities	382.17	-	60	881.34	913.72	-
Cash & Short-Term Investments	1,375	1,081	1,336	1,132	1,223	120.34
Cash Growth	43.18%	-19.10%	18.03%	-7.45%	916.56%	63.69%
Accounts Receivable	77.5	83.29	41.78	47.15	34.01	43.72
Other Receivables	11.01	20.45	8.76	14.14	13.45	5.97
Receivables	88.51	103.74	50.54	61.29	47.46	49.69
Inventory	469.36	399.32	327.95	337.94	263.25	145.27
Other Current Assets	45.63	32.54	41.18	26.01	19.15	34.96
Total Current Assets	1,979	1,617	1,756	1,557	1,553	350.26
Property, Plant & Equipment	792.87	671.58	464.46	319.93	258.73	155.11
Long-Term Investments	172.99	178.91	159.8	178.17	121.27	32.81
Goodwill	48.13	48.13	48.13	-	-	-
Other Intangible Assets	392.43	402	83	38.92	32.38	32.47
Long-Term Deferred Tax Assets	31.27	27.44	10.73	12.64	9.82	1.62
Long-Term Deferred Charges	3.12	3.4	5.95	5.09	7.41	1.62
Other Long-Term Assets	41.13	32.55	44.83	113.77	30.24	14.82
Total Assets	3,461	2,981	2,573	2,226	2,013	588.71
Accounts Payable	57.03	46.32	42.73	34.65	18	8.19
Accrued Expenses	153.49	192.09	161.28	119.18	94.68	62.14
Short-Term Debt	-	-	70	30	16	10.5
Current Portion of Long-Term Debt	8.14	0.59	1.18	7.27	6.09	5
Current Portion of Leases	-	5.83	10.1	6.26	7.46	-
Current Income Taxes Payable	50.98	27.1	19.86	13.3	9.35	3.38
Current Unearned Revenue	32.65	45.66	44.4	38.65	32.32	16.71
Other Current Liabilities	65.4	88.39	238.62	162.57	10.63	3.5
Total Current Liabilities	367.68	405.97	588.17	411.88	194.53	109.41
Long-Term Debt	3.76	-	0.59	1.77	10.23	23.59
Long-Term Leases	9.96	4.87	7.99	7.29	6.8	-
Long-Term Unearned Revenue	38.58	11.26	8.74	7.06	7.3	5.62
Long-Term Deferred Tax Liabilities	2.5	2.74	5.49	6.92	3.16	-
Other Long-Term Liabilities	1.02	1.02	-	-	-	-
Total Liabilities	423.5	425.85	610.98	434.91	222.02	138.62
Common Stock	141.01	97.39	66.86	66.67	66.67	50
Additional Paid-In Capital	698.66	784.5	724.04	1,013	1,268	159.47
Retained Earnings	2,143	1,685	1,141	716.83	425.49	250.9
Treasury Stock	-	-59.99	-59.99	-59.99	-	-
Comprehensive Income & Other	6.4	9.6	34.96	27.22	17.89	-0.01
Total Common Equity	2,989	2,516	1,907	1,763	1,778	460.36
Minority Interest	48.43	38.5	54.86	27.75	12.95	-10.27
Shareholders' Equity	3,037	2,555	1,962	1,791	1,791	450.09
Total Liabilities & Equity	3,461	2,981	2,573	2,226	2,013	588.71
Total Debt	21.87	11.29	89.86	52.59	46.58	39.09
Net Cash (Debt)	1,353	1,070	1,247	1,080	1,177	81.25
Net Cash Growth	42.75%	-14.18%	15.46%	-8.26%	1348.33%	-
Net Cash Per Share	9.59	7.58	8.79	7.60	8.53	0.77
Filing Date Shares Outstanding	141.01	140.57	139.92	139.52	140.17	105.13
Total Common Shares Outstanding	141.01	140.57	139.92	140.17	140.17	105.13
Working Capital	1,611	1,211	1,168	1,146	1,359	240.85
Book Value Per Share	21.20	17.90	13.63	12.58	12.69	4.38
Tangible Book Value	2,548	2,066	1,776	1,724	1,746	427.89
Tangible Book Value Per Share	18.07	14.70	12.69	12.30	12.45	4.07
Buildings	-	262.05	173.2	150.44	81.94	69.27
Machinery	-	590.75	402.93	277.15	223.7	141.71
Construction In Progress	-	46.34	47.84	14.99	37.31	17.64

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.